These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19569568)

  • 1. Alzheimer's drug pipeline is robust, and usage is quickly expanding.
    Sipkoff M
    Manag Care; 2009 Jun; 18(6):31-2. PubMed ID: 19569568
    [No Abstract]   [Full Text] [Related]  

  • 2. Alzheimer's drug costs likely to rise as boomers age.
    Manag Care; 2010 Nov; 19(11):43. PubMed ID: 21141377
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacoeconomics of Alzheimer's disease.
    Fillit HM
    Am J Manag Care; 2000 Dec; 6(22 Suppl):S1139-44; discussion S1145-8. PubMed ID: 11142178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy.
    Fillit H; Hill JW; Futterman R
    Fam Med; 2002; 34(7):528-35. PubMed ID: 12144008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease. Three-score years and then?
    Bryan J
    Health Serv J; 1998 Aug; 108(5619):suppl 4-5, 7-8. PubMed ID: 10185456
    [No Abstract]   [Full Text] [Related]  

  • 6. Donepezil and Alzheimer's dementia.
    Earl-Slater A; Walley T
    Clin Perform Qual Health Care; 2000; 8(1):47-51. PubMed ID: 11183967
    [No Abstract]   [Full Text] [Related]  

  • 7. Tacrine granted marketing approval for Alzheimer's disease.
    Clin Pharm; 1993 Dec; 12(12):873, 876. PubMed ID: 8137602
    [No Abstract]   [Full Text] [Related]  

  • 8. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
    Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
    Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early diagnosis and management of Alzheimer's disease.
    Duncan BA; Siegal AP
    J Clin Psychiatry; 1998; 59 Suppl 9():15-21. PubMed ID: 9720482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrine for Alzheimer's.
    Handly M
    Am Pharm; 1991 Dec; NS31(12):8. PubMed ID: 1763782
    [No Abstract]   [Full Text] [Related]  

  • 11. Early Alzheimer's diagnosis can delay disease progression and help reduce costs, complications.
    Healthc Demand Dis Manag; 1997 May; 3(5):71-5. PubMed ID: 10174896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Datawatch: Update on Rx drug spending.
    Bus Health; 2001 Sep; 19(8):48. PubMed ID: 11665673
    [No Abstract]   [Full Text] [Related]  

  • 13. Alzheimer's disease drug development and testing at the National Institute on Aging.
    Buckholtz NS
    Psychopharmacol Bull; 1994; 30(1):15-7. PubMed ID: 7972623
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA approves groundbreaking Alzheimer's drug.
    Provider; 2004 Feb; 30(2):24, 27. PubMed ID: 14964917
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of tacrine in Alzheimer's disease: or non-effect?
    Talmont DM; Bowden M
    Med J Aust; 1995 Jan; 162(1):52-3. PubMed ID: 7710524
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic considerations in Alzheimer's disease.
    Meek PD; McKeithan K; Schumock GT
    Pharmacotherapy; 1998; 18(2 Pt 2):68-73; discussion 79-82. PubMed ID: 9543467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of early stages of Alzheimer's disease: New guidelines are in the pipeline].
    Winblad B; Kivipelto M; Andersen P; Johansson G; Andreasen N
    Lakartidningen; 2013 Sep 11-17; 110(37):1613. PubMed ID: 24163935
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of Alzheimer's disease utilising the best available evidence-based medicine -- utopia?].
    Stoppe G; Pirk O; Haupt M
    Gesundheitswesen; 2005 Jan; 67(1):20-6. PubMed ID: 15672302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Alzheimer's endpoints?
    Aldridge S
    Nat Biotechnol; 2008 May; 26(5):482. PubMed ID: 18464762
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA user fee may speed approval of Alzheimer's, Parkinson's drugs.
    Geriatrics; 1992 Dec; 47(12):15-6. PubMed ID: 1446840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.